Avricore Health (TSE:AVCR) has released an update.
Avricore Health Inc. has reported its first profitable quarter in early 2024, with a significant comprehensive income of $168,537 and a strong year-over-year revenue increase of 79%. The company’s gross profit soared by 130% to $484,791, indicating solid growth and operational efficiency. This financial upturn comes ahead of the company’s anticipation of expanded pharmacist-led chronic disease prescribing in Canadian provinces.
For further insights into TSE:AVCR stock, check out TipRanks’ Stock Analysis page.
